A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors
Clinical trial NCT06394713 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06394713
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-15
- Primary completion
- 2025-06-15
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.